CTRI/2019/03/018049已完成未知
18F- FDG PET CT based adaptive radiotherapy in pharyngeal and laryngeal cancer patients â?? A study on change in target volumes and reduction in OAR doses
Basavatrakam Indo American Cancer Hospital and Research Institute Hyderabad0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Histological proven pharyngeal & laryngeal cancer patients
- •2. ECOG Performance status 0-1
- •3. Undergoing Definitive chemoradiation
- •4. Treated with Conformal Radiotherapy techniques
排除标准
- •1. Stage IVB disease
- •2. ECOG Performance status 2 or more
- •3. Previous radiation exposure to head and neck
- •4. Patients who has undergone head and neck surgery / neck dissection
- •5. Patients who have recurrence
研究者
相似试验
招募中
3 期
Radiotherapy Vs Observation for post chemotherapy residual mass in advanced SeminomaCTRI/2021/11/038265Tata Memorial Centre Department of Atomic Energy Clinical Trial Centre
招募中
不适用
PET/CT based radiotherapy treatment planning for cancermalignant tumorJPRN-UMIN000003522Yokohama City University, School of Medicine100
已完成
不适用
Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer.ovarian cancerNL-OMON29961Academisch Ziekenhuis Maastricht20
招募中
不适用
radiation therapy planning with PET-CT for head and neck cancerJPRN-UMIN000023830Tokyo medical and dental university40
进行中（未招募）
不适用
Very early FDG-PET/CT-response adapted therapy for advanced stage Hodgkin Lymphoma, a randomized phase III non-inferiority study of the EORTC Lymphoma Group.Advanced stage Hodgkin's lymphomaMedDRA version: 15.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-005473-22-DKEORTC570